These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 369921)

  • 21. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.
    Rosenberg C; Lauritzen L; Brix J; Jørgensen JB; Kofod P; Bayer LB
    Psychopharmacol Bull; 2007; 40(1):63-73. PubMed ID: 17285097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant activity and pharmacological interactions of ciclazindol.
    Ghose K; Rama Rao VA; Bailey J; Coppen A
    Psychopharmacology (Berl); 1978 Apr; 57(1):109-14. PubMed ID: 96461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noxiptilin (Agedal)--a new tricyclic antidepressant with a faster onset of action? A double-blind, multicentre comparison with amitriptyline.
    Lingjaerde O; Asker T; Bugge A; Engstrand E; Eide A; Grinaker H; Herlofsen H; Ose E; Ofsti E
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):26-35. PubMed ID: 788000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression.
    Theohar C; Fischer-Cornelssen K; Brosch H; Fischer EK; Petrovic D
    Arzneimittelforschung; 1982; 32(7):783-7. PubMed ID: 6751339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine.
    Keskinbora K; Aydinli I
    Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT; Glaudin V; Panagides J; Gilvary E
    Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.
    Kaumeier S; Dohren J; Flach D
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):108-13. PubMed ID: 401705
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lofepramine: a comparative clinical study with amitriptyline].
    Mariategui J; Chávez H; Olivares A
    Acta Physiol Lat Am; 1978 Sep; 24(3):201-9. PubMed ID: 375679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of tricyclic antidepressant response: a critical review.
    Bielski RJ; Friedel RO
    Arch Gen Psychiatry; 1976 Dec; 33(12):1479-89. PubMed ID: 793564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical results with pizotyline in depression.
    Olgiati S; Calobrisi A
    Dis Nerv Syst; 1974 Jan; 35(1):35-8. PubMed ID: 17894054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
    Iakovlev VA
    Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical profile and serum concentration of viloxazine as compared to amitriptyline.
    Müller-Oerlinghausen B; Rüther E
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):321-37. PubMed ID: 386390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative trial of L-tryptophan and amitriptyline in depressive illness.
    Herrington RN; Bruce A; Johnstone EC; Lader MH
    Psychol Med; 1976 Nov; 6(4):673-8. PubMed ID: 794897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled double-blind clinical trial between maprotiline and amitriptyline in depressive illness.
    Okasha A; Sadek A
    J Egypt Med Assoc; 1976; 59(5-6):557-62. PubMed ID: 801741
    [No Abstract]   [Full Text] [Related]  

  • 38. Three double-blind comparative trials of mianserine (ORG GB 94) and amitriptyline in the treatment of depressive illness.
    Jaskari MO; Ahfors UG; Ginman L; Lydekcne K; Tienari P
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):101-3. PubMed ID: 360231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind study of dothiepin hydrochloride (Prothiaden) and amitriptyline in out-patients with masked depression.
    Dahl LE; Dencker SJ; Lundin L
    J Int Med Res; 1981; 9(2):103-7. PubMed ID: 7014282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.
    Miccoli L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1978; 33(3):243-55. PubMed ID: 371351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.